Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

Bridge the gap! Experts address ASCVD risks in rural areas and provide their best practices to create healthier, more connected communities.

Chapter 1: Diagnosing ASCVD

6 chapters
1.00 credits
60 minutes
Play All
CME/CE
ReachMD Healthcare Image
Media formats available:
Details
Program chapters
Presenters
Related
  • Overview

    This on-demand knowledge primer explores key challenges and evidence-based strategies for improving atherosclerotic cardiovascular disease (ASCVD) management in rural populations. Led by two expert faculty members, the program provides a comprehensive overview of disparities in ASCVD care, guideline-directed therapies, and practical approaches to overcoming barriers in rural settings. Participants will gain essential knowledge to enhance patient outcomes and optimize cardiovascular care in underserved communities.

  • Disclosure of Conflicts of Interest

    Faculty Disclosure

    All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

    Ty Gluckman, MD, faculty for this educational event, is a consultant OptumRx.

    Rishi Wadhera, MD, faculty for this educational event, is a current consultant with Abbott Vascular and a former consultant with Chambercardio.

    All of the relevant financial relationships listed for these individuals have been mitigated. No other speakers, authors, planners or content reviewers have any relevant financial relationship to disclose.

  • Target Audience

    This activity is intended for cardiologists, lipidologists, primary care physicians, specialty and non-specialty nurse practitioners and physician associates, and pharmacists who care for patients with atherosclerotic cardiovascular disease.

  • Learning Objectives

    After completing this activity, participants should be better able to:

    • Review characteristics of novel nonstatin medications that can be used to achieve LDL-C targets
    • Discuss the current and emerging role of lipoprotein(a) assessment
    • Describe barriers to equitable care for individuals living in rural communities
  • Accreditation and Credit Designation Statements

    In support of improving patient care, this activity has been planned and implemented by UK HealthCare CECentral and Partners for Advancing Clinical Education. University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    CME
    This enduring material is designated for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

    CPE
    This knowledge-based activity will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

    Other
    UK Healthcare CECentral certifies this activity for 1.00 hour of participation.

    CNE
    The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour.

  • Disclaimer

    The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

    Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias.

    Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

  • Provider(s)/Educational Partner(s)

    Jointly provided by UK Healthcare CECentral and Partners for Advancing Clinical Education.

  • Commercial Support

    This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

NEW FEATURES:

Register

We're glad to see you're enjoying Global Cardiology Academy…
but how about a more personalized experience?

Register for free